Moses Owade-Were writes: Recent years have seen significant reductions in AIDS-related deaths as well as new HIV infections at global level, coupled with extensive rollout of ARVs. The gains are impressive: an estimated 18.2 million people were accessing antiretroviral therapy in 2016, up from 7.5 million in 2010. However, while AIDS